                         SEQUENCE LISTING

<110>  INSERM
       UNIVERSITE DE NANTES
 
<120>  AN ISOLATED DONOR MHC-DERIVED PEPTIDE AND USES THEREOF

<130>  14069GUILLONNEAU/AS

<150>  EP 14 163 072.3
<151>  2014-04-01

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Common Sequence

<400>  1

Ser Asp Val Gly Glu Tyr Arg Ser 
1               5               


<210>  2
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  Subdominant peptide Bu31

<400>  2

Tyr Leu Arg Tyr Asp Ser Asp Val Gly Glu Tyr Arg Ala Val Thr Glu 
1               5                   10                  15      


<210>  3
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  Peptide 32

<400>  3

Asp Ser Asp Val Gly Glu Tyr Arg Ala Val Thr Glu Leu Gly Arg Pro 
1               5                   10                  15      


<210>  4
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-1

<400>  4

Tyr Leu Arg Tyr Asp Ser Asp Val Gly 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-2

<400>  5

Leu Arg Tyr Asp Ser Asp Val Gly Glu 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-3

<400>  6

Arg Tyr Asp Ser Asp Val Gly Glu Tyr 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-4

<400>  7

Tyr Asp Ser Asp Val Gly Glu Tyr Arg 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-5

<400>  8

Asp Ser Asp Val Gly Glu Tyr Arg Ala 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-6

<400>  9

Ser Asp Val Gly Glu Tyr Arg Ala Val 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-7

<400>  10

Asp Val Gly Glu Tyr Arg Ala Val Thr 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  9-mer peptide 31-8

<400>  11

Val Gly Glu Tyr Arg Ala Val Thr Glu 
1               5                   


<210>  12
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  11-mer peptide 31-09

<400>  12

Gly Glu Tyr Arg Ala Val Thr Glu Leu Gly Arg 
1               5                   10      


<210>  13
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  12-mer peptide 31-10

<400>  13

Tyr Leu Arg Tyr Asp Ser Asp Val Gly Glu Tyr Arg 
1               5                   10          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  12-mer peptide 31-11

<400>  14

Val Gly Glu Tyr Arg Ala Val Thr Glu Leu Gly Arg 
1               5                   10          


<210>  15
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  13-mer peptide 31-12

<400>  15

Asp Val Gly Glu Tyr Arg Ala Val Thr Glu Leu Gly Arg 
1               5                   10              


<210>  16
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  14-mer peptide 31-13

<400>  16

Tyr Leu Arg Tyr Asp Ser Asp Val Gly Glu Tyr Arg Ala Val 
1               5                   10                  


<210>  17
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  14-mer peptide 31-14

<400>  17

Ser Asp Val Gly Glu Tyr Arg Ala Val Thr Glu Leu Gly Arg 
1               5                   10                  


<210>  18
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  15-mer peptide 31-15

<400>  18

Leu Arg Tyr Asp Ser Asp Val Gly Glu Tyr Arg Ala Val Thr Glu 
1               5                   10                  15  


<210>  19
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  Peptide 33

<400>  19

Asn Arg Glu Glu Tyr Ala Arg Phe Asp Ser Asp Val Gly Glu Tyr Arg 
1               5                   10                  15      


<210>  20
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  Peptide 34

<400>  20

Tyr Ala Arg Phe Asp Ser Asp Val Gly Glu Tyr Arg Ala Val Thr Glu 
1               5                   10                  15      


<210>  21
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Common Sequence

<400>  21

Asp Ser Asp Val Gly Glu Tyr Arg 
1               5               


<210>  22
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  Control tetramer RT1.Aa/MTF-E

<400>  22

Ile Leu Phe Pro Ser Ser Glu Arg Leu Ile Ser Asn Arg 
1               5                   10              


